Better antibody monitoring after kidney transplant
Part of Immune system & allergy, Kidney & urinary clinical trials.
This study tests a new way to monitor harmful antibodies after a kidney transplant. It may help prevent transplant rejection over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received a high-risk kidney transplant or are about to get one.
- You have had a kidney transplant in the last 12 months, or you are getting one soon.
- You are able to understand and agree to the study.
- For one part of the study, you must not be 'sensitized' (have pre-existing antibodies) before transplant.
- You have not had your transplant more than 2 weeks ago for some parts of the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new blood test (called cfDNA) that may help doctors detect early signs of kidney transplant rejection before problems develop. The goal is to help keep your transplanted kidney healthy longer by catching issues early.
This study looks at how memory B cells (a type of immune cell) relate to antibodies against HLA in people waiting for a kidney transplant. It aims to better understand immune responses, which could help improve transplant matching and outcomes.
This Phase 2 study looks at whether blood test “biomarkers” can guide safely changing anti-rejection medicines after an ABO-compatible kidney transplant. It may help some people reduce certain medicines while keeping the new kidney protected from rejection.
This trial uses a personalized approach (including tacrolimus medication planning and monitoring) to better understand how a kidney transplant is doing. It may help your transplant team tailor care to your kidney function over time.
This study looks at how well a new blood test works to monitor kidney health after a transplant. It might help doctors catch problems early without needing a biopsy.
This study is testing a blood test that looks for tiny pieces of the donor's DNA in your blood to check how your new kidney is doing. It may help doctors monitor your transplant and spot problems early, possibly without needing a biopsy.
Hear when a new Kidney Transplant trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.